|Bid||138.05 x 800|
|Ask||144.02 x 1300|
|Day's Range||137.91 - 140.12|
|52 Week Range||106.11 - 148.23|
|Beta (3Y Monthly)||1.30|
|PE Ratio (TTM)||802.89|
|Earnings Date||Jul 31, 2019|
|Forward Dividend & Yield||1.56 (1.12%)|
|1y Target Est||145.17|
McKesson (MCK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
US drug manufacturers and distributors are under the gun. Two decades into the opioid addiction epidemic that has killed more than 200,000 people, the industry is now confronting a cluster of lawsuits and enforcement actions seeking to hold them accountable for a health crisis that adds up to an economic burden of $78.5bn annually. have recently settled with the state of Oklahoma for $270m and $85m respectively.
Charles Schwab told employees it’s scrapping an annual trip to Hawaii or other popular destinations for high-performing employees, saying the event was rooted in “a different era” and now poses “significant reputational risks,” the Wall Street Journal reported, citing a company email to employees. In place of next year’s trip to Hawaii for about 200 employees, the company will give those making the Chairman’s Club an after-tax check for $5,000 and a paid week off. Ending the Hawaii trip reflects how no expense is overlooked in an era when Schwab faces pricing pressures from a new generation of competitors, such as Menlo Park-based Robinhood, with commission-free stock trades and margin rates on most loans about half of what Schwab charges.
Top-line growth and better-than-expected segmental performance are likely to aid McKesson (MCK) in Q1. However, rise in adjusted operating expenses is likely to be a dampener.
Shares of drug distributors and pharmacy-benefit-manager owners got a boost on Thursday after the Trump administration said it would be withdrawing its plan to overhaul the rebates that drugmakers give to middlemen in Medicare.
While many investors are focused on the negative impacts of tariffs and the U.S.-China trade war on corporate profits, they may be overlooking another sizable threat, which is rapidly rising labor costs. The median company in the S&P 500 Index (SPX) pays out 13% of its revenues in the form of employee compensation, and these costs grew by 3% in 2018, the fastest pace during the current economic expansion, which began in June 2009, Goldman Sachs reported this week. Goldman believes that stocks with lower than average labor costs as a percentage of sales are well-positioned to outperform in this environment.
McKesson Corp NYSE:MCKView full report here! Summary * Perception of the company's creditworthiness is positive * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for MCK with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting MCK. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $2.20 billion over the last one-month into ETFs that hold MCK are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swap | PositiveThe current level displays a positive indicator. MCK credit default swap spreads are near the lowest level of the last one year and indicate improvement in the market's perception of the company's credit worthiness.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Rite Aid (RAD) expands the availability of its Thrifty Ice Cream brand in select stores in Delaware, New York, Maryland, New Jersey and Pennsylvania.
Is McKesson Corporation (NYSE:MCK) a good dividend stock? How can we tell? Dividend paying companies with growing...
McKesson Corporation (MCK) announced today that its first quarter fiscal 2020 financial results will be released on Wednesday, July 31, 2019 following the close of market. The company will host a conference call at 5:00 PM Eastern Time (2:00 PM Pacific Time) the same day to discuss the financial results. A live audio webcast of the conference call will be available on McKesson’s Investor Relations website at http://investor.mckesson.com, along with the company’s earnings press release, financial tables and slide presentation.
Change Healthcare, Inc., a scaled healthcare information technology company, began trading on the Nasdaq Global Select Market under the trading symbol "CHNG." McKesson holds the majority ownership stake in Change Healthcare’s operating subsidiary. "Congratulations to Change Healthcare on this significant milestone in the company’s history. For McKesson, this is an important next step in our efforts to unlock value for McKesson shareholders from our investment in the Change Healthcare business," said Brian Tyler, chief executive officer of McKesson.
Without commenting on Allergan (AGN) shares of which we own, or AbbVie (ABBV) which we do not, health care companies in general are noncyclical — health care consumption is stable and independent of the whims of the global economy. The world’s population is aging rapidly, and as people get older they consume more health care services. The media (mainly “60 Minutes”) has likened drug distributors’ exposure to opioid lawsuits to Philip Morris International’s (PM) $150 billion tobacco settlement.
McKesson (MCK) is gaining from strong segmental performance and solid prospects in the pharmaceutical and medical supplies distribution market.
Amgen produces relatively few drugs, but that's doesn't mean it's any less essential or profitable. Here's a look at the $120B company.
California Gov. Gavin Newsom urged Bay Area business leaders to focus on the advantages of doing business in the Golden State while also promising action on the state's homeless problem that's garnering national headlines.
Echo, the U.K. startup that offers an app to help you manage your medication and order repeat prescriptions for delivery, has been acquired by healthcare company McKesson, owner of LloydsPharmacy. Echo was founded in 2015 by Sai Lakshmi, who previously worked in biz dev for Apple, and Stephen Bourke, who (notably) was previously a manager at LloydsPharmacy’s online doctor service. Lakshmi stepped down as CEO of Echo in August last year and was subsequently replaced by ex-HelloFresh International COO Roger Hassan.
It was anything but a high-conviction win, but stocks managed to hold onto a piece of Monday's gain. The S&P 500 ended the day up 0.09%, just barely able to hang on to its place above a pivotal support level.Source: Allan Ajifo via Wikimedia (Modified)Facebook (NASDAQ:FB) did a great deal of the heavy lifting, rallying more than 4% on the heels of news that it was planning to launch its own cryptocurrency. Chesapeake Energy (NYSE:CHK) wasn't far behind though, gaining more than 3% thanks to rebounding natural gas prices, which hit multi-month lows just a few days back. A multi-week selloff from CHK set the stage rather nicely though.Advanced Micro Devices (NASDAQ:AMD) led the losers, off almost 4% after Goldman Sachs posted some broadly bearish thoughts on software names. AMD was guilty by indirect association though, and is teetering on its worst losing streak in eight months.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * The 10 Best Index Funds to Buy and Hold Headed into Tuesday's trading action though, it's the stock charts of McKesson (NYSE:MCK), Gilead Sciences (NASDAQ:GILD) and Dish Network (NASDAQ:DISH) that are worth the closest looks. Here's why, and what's likely to happen next. Dish Network (DISH)On Tuesday of last week we pointed out Dish Network was putting the finishing touches on a move above a significant technical ceiling. But, the nature of the effort was less than convincing. It was going to require a confirmation of sorts that DISH shares were ready to remain above that resistance.We moved toward that goal over the course of last week, but yesterday we effectively sealed the deal. The shape and placement of Monday's bar says the bulls mean business. Now that the heavy lifting is done the stock has a lot of room to continue recovering its 2017 and 2018 losses. Click to Enlarge * The ceiling in question is right around $36.90, plotted in yellow on both stock charts. That was a resistance level in late May, but as the weekly chart shows, it was a huge problem in mid-2018. * Monday's bar is ideal. A decent open only had to kiss the former technical ceiling to drive the stock to its highest close in over a year. * Bolstering the bullish argument is how much volume took shape behind yesterday's gain. But, this also wasn't the first time we've seen a volume surge behind major forward progress. The bulls are starting to form, en masse. * The weekly chart puts it all in perspective. There's not another major technical ceiling in sight until the $66.50 area, marked in blue. McKesson (MCK)A little over a week ago McKesson was featured as a budding breakout candidate. It has crossed back above all of its key moving average lines, and though a rather important technical ceiling remained above, the momentum was encouraging.That resistance line ended up being tested as expected, although MCK shares failed to clear it. They're still in the hunt for that breakout move though, and now they're even closer to starting it with an ideal bull signal. * 7 Top-Rated Biotech Stocks to Invest In Today Click to Enlarge * The resistance level to watch is the line that traces all the major peaks going back to October, including last week's. It's plotted in yellow on both stock charts. * It's evident on both charts, but the weekly chart puts the current converging wedge pattern in perspective. This is one of the best chances we've seen of reversing a multi-year selloff. * Although the last one didn't offer much help, the purple 50-day moving average line is about to cross above the white 200-day line. That will draw a crowd of bulls no matter what, but especially if McKesson can break above its falling resistance line. Gilead Sciences (GILD)Take it with a grain of salt, as we've seen it before, to no avail. But, Gilead Sciences shares are knocking on the door of a key break above a well-established resistance line. Although there's another major ceiling beyond that one that could disrupt the chart that's admittedly easy to disrupt, there's also a chance that the bears have inflicted enough damage and that the company itself has finally addressed the drug-cost issues that have proven so problematic for the stock's price. * Like McKesson, Gilead shares have been range-bound for several weeks after a two-year spell. It's one reasonably compelling way to end weakness and kick off some progress. * Just above the resistance currently at $67.15 is the 200-day moving average line at $68.14, plotted in white on both stock charts. That line is still a make-or-break level. The key will be making that move at a sustainable pace. * The weekly chart not only serves as a reminder that huge swings in both directions are possible, but that last year's peak around $79 could be where any breakout move finally comes to a close.As of this writing, James Brumley did not hold a position in any of the aforementioned securities. You can learn more about James at his site, jamesbrumley.com, or follow him on Twitter, at @jbrumley. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 5 Red-Hot IPO Stocks to Buy for the Long Run * 5 Stocks to Buy for $20 or Less * 4 Dow Jones Stocks Ready to Rise Compare Brokers The post 3 Big Stock Charts for Tuesday: McKesson, Dish Network and Gilead Sciences appeared first on InvestorPlace.
McKesson Corporation (MCK) today announced that its board of directors elected Dr. Ken Washington as a new independent director, effective July 1, 2019. With the election of Dr. Washington, McKesson’s board of directors increases from nine to ten members, nine of whom are independent. “Ken’s years of experience in technology, research, and privacy strategy at complex global organizations will be invaluable to the board as we maintain oversight of the company and provide the leadership team with strategic guidance,” said Edward Mueller, McKesson’s independent board chair.
Fort Worth’s position as a finalist for Quantum Health Inc.’s headquarters shows the city has the talent and other attributes that major health care companies need, according to a top chamber official.
Weak prices for generics, potential opioid liability, and rumbles of change coming from Washington pose challenges. But the market reaction has been overdone.
Change Healthcare, an independent health care technology platform, announced terms for its proposed initial public offering Friday. The IPO Terms The Nashville, Tennessee-based company plans to offer ...
Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 due to various reasons. Nevertheless, the data show elite investors' consensus picks have done well on average over the long-term. The top 20 stocks among hedge funds beat the S&P […]